
    
      Scheme:

      Patients will receive different chemotherapy regimens depending on the pathological type.

      Squamous cell carcinoma:Docetaxel/Cisplatin and concurrent radiation (46Gy/23f) followed by
      surgery, consolidate Docetaxel/Cisplatin 2 cycles.

      Non-squamous cell carcinoma:Pemetrexed/Cisplatin and concurrent radiation (46Gy/23f) followed
      by surgery, consolidate Pemetrexed/Cisplatin 2 cycles.
    
  